Cascadian Therapeutics Inc (CASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2001 | 06-2001 | 03-2001 | 12-2000 | 09-2000 | |
| Sales | 1,553 | 3,532 | 746 | 678 | 837 |
| Gross Profit | 1,550 | 2,280 | 740 | 660 | 830 |
| Operating Expenses | 6,130 | 9,400 | 8,440 | 8,520 | 8,230 |
| Operating Income | -4,577 | -5,868 | -7,694 | -7,842 | -7,393 |
| Other Income | -13 | -1,262 | -16 | 2 | -17 |
| Pre-tax Income | -4,590 | -7,130 | -7,710 | -7,840 | -7,410 |
| Income Tax | 0 | 0 | 0 | -280 | 0 |
| Net Income Continuous | -4,604 | -11,007 | -7,770 | -7,765 | -7,466 |
| Net Income | $-4,604 | $-11,007 | $-7,770 | $-7,765 | $-7,466 |
| EPS Basic Total Ops | -3.24 | -7.92 | -5.76 | -5.76 | -5.76 |
| EPS Basic Continuous Ops | -3.24 | -7.81 | -5.60 | -5.77 | -5.60 |
| EPS Diluted Total Ops | -3.24 | -7.92 | -5.76 | -5.76 | -5.76 |
| EPS Diluted Continuous Ops | -3.24 | -7.81 | -5.60 | -5.77 | -5.60 |
| EBITDA(a) | $-4,547 | $-5,858 | $-7,514 | $-7,682 | $-7,173 |